Cargando…

Viral neutralization by antibody-imposed physical disruption

In adaptive immunity, organisms produce neutralizing antibodies (nAbs) to eliminate invading pathogens. Here, we explored whether viral neutralization could be attained through the physical disruption of a virus upon nAb binding. We report the neutralization mechanism of a potent nAb 8C11 against th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Qingbing, Jiang, Jie, He, Maozhou, Zheng, Zizheng, Yu, Hai, Li, Tingting, Xue, Wenhui, Tang, Zimin, Ying, Dong, Li, Zekai, Song, Shuo, Liu, Xinlin, Wang, Kaihang, Zhang, Zhiqing, Wang, Daning, Wang, Yingbin, Yan, Xiaodong, Zhao, Qinjian, Zhang, Jun, Gu, Ying, Li, Shaowei, Xia, Ningshao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2019
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936700/ https://www.ncbi.nlm.nih.gov/pubmed/31818956 http://dx.doi.org/10.1073/pnas.1916028116

Ejemplares similares

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection
por: Liu, Xinlin, et al.
Publicado: (2019)

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding
por: He, Maozhou, et al.
Publicado: (2021)

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
por: Li, Zhihai, et al.
Publicado: (2017)

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
por: Wang, Daning, et al.
Publicado: (2020)

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
por: Li, Zhihai, et al.
Publicado: (2018)

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
por: Zhang, Zhiqing, et al.
Publicado: (2018)

Construction of a bacterial surface display system based on outer membrane protein F
por: Chen, Tingting, et al.
Publicado: (2019)

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5
por: Xia, Lin, et al.
Publicado: (2016)

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression
por: Zhou, Lizhi, et al.
Publicado: (2022)

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
por: Wei, Minxi, et al.
Publicado: (2018)

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
por: Zhang, Zhiqing, et al.
Publicado: (2016)

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs
por: Huang, Weijin, et al.
Publicado: (2020)

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions
por: Zhou, Lizhi, et al.
Publicado: (2020)

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
por: Huang, Yang, et al.
Publicado: (2020)

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
por: Li, Tingting, et al.
Publicado: (2022)

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
por: Wang, Kaihang, et al.
Publicado: (2021)

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
por: Li, Tingting, et al.
Publicado: (2020)

Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209
por: Ju, Bin, et al.
Publicado: (2022)

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
por: Li, Tingting, et al.
Publicado: (2021)

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
por: Wang, Siling, et al.
Publicado: (2022)

A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity
por: Chen, Zihao, et al.
Publicado: (2022)

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
por: Liu, Liqin, et al.
Publicado: (2022)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody
por: Wang, Daning, et al.
Publicado: (2015)

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody
por: Xu, Longfa, et al.
Publicado: (2017)

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
por: Huang, Yang, et al.
Publicado: (2022)

An Optimized High-Throughput Neutralization Assay for Hepatitis E Virus (HEV) Involving Detection of Secreted Porf2
por: Liu, Chang, et al.
Publicado: (2019)

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
por: Qian, Ciying, et al.
Publicado: (2022)

Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice
por: Xue, Wenhui, et al.
Publicado: (2022)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
por: Zhao, Dongping, et al.
Publicado: (2022)

Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient
por: Chen, Zihao, et al.
Publicado: (2022)

Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation
por: Deng, Tingting, et al.
Publicado: (2022)

Nanoparticle-based multivalent human antibodies offer potent and broad neutralization against Omicron sublineages
por: Wang, Yizhen, et al.
Publicado: (2023)

Structures of pseudorabies virus capsids
por: Wang, Guosong, et al.
Publicado: (2022)

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
por: Li, Yike, et al.
Publicado: (2020)

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
por: Wu, Qian, et al.
Publicado: (2023)

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design
por: Chen, Tingting, et al.
Publicado: (2023)

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10
por: Zhu, Rui, et al.
Publicado: (2018)

A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity
por: Wang, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_11cm3arsffgdn70vm7g1eg9ab5